Compare BKSY & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKSY | QDEL |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | 321 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | 2022 |
| Metric | BKSY | QDEL |
|---|---|---|
| Price | $32.50 | $14.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $28.50 | $28.25 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $27.03 | $3.51 |
| Revenue Next Year | $29.21 | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.12 | $9.92 |
| 52 Week High | $52.88 | $35.58 |
| Indicator | BKSY | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 56.65 |
| Support Level | $30.16 | $10.39 |
| Resistance Level | $42.75 | $15.76 |
| Average True Range (ATR) | 4.41 | 1.06 |
| MACD | -1.68 | 0.18 |
| Stochastic Oscillator | 11.81 | 59.18 |
BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.